Discontinuous to Continuous Therapy with 0.2 μg/day Fluocinolone Acetonide implant (FAc) Leads to Reduction in Treatment Frequency for Diabetic Macular Edema (DME)

被引：0
|
作者：
Adams, Olufemi E. [1 ]
Schechet, Sidney [1 ]
Hariprasad, Seenu [1 ]
机构：
[1] Univ Chicago, Ophthalmol, Chicago, IL 60637 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2614
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Optimization of diabetic macular edema (DME) therapy following 0.2 μg/day fluocinolone acetonide (FAc) implant administration
    Gonzalez, Victor H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [2] Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)
    Liu, John
    Coney, Joseph
    Schartman, Jerome
    Miller, David G.
    Zegarra, Hernando
    Rao, Llewelyn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [3] Effective Duration of Fluocinolone Acetonide (FAc) Implant in the Treatment of Diabetic Macular Edema
    Saigal, Khushi
    El Hamichi-Potamkin, Sophia
    Khurshid, Syed Gibran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] Prior steroid response as a predictor of real-world IOP safety with 0.2 μg/day fluocinolone acetonide (FAc) in diabetic macular edema (DME) therapy
    Lai, James C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Progression of diabetic retinopathy in patients treated with 0.2 μg/day fluocinolone acetonide (FAc) implants for diabetic macular edema (DME): a fellow eye controlled analysis
    Iezzi, Raymond
    Kapik, Barry
    Green, Ken E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [6] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [7] Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
    McCluskey, Jessica D.
    Kaufman, Paul L.
    Wynne, Kathy
    Lewis, Gregory
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2019, 12 : 93 - 102
  • [8] Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
    Meireles, A.
    Goldsmith, C.
    El-Ghrably, I.
    Erginay, A.
    Habib, M.
    Pessoa, B.
    Coelho, J.
    Patel, T.
    Tadayoni, R.
    Massin, P.
    Atorf, J.
    Augustin, A. J.
    EYE, 2017, 31 (05) : 684 - 690
  • [9] Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency
    Adams, Olufemi E.
    Schechet, Sidney A.
    Hariprasad, Seenu M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (02) : 612 - 619
  • [10] Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
    A Meireles
    C Goldsmith
    I El-Ghrably
    A Erginay
    M Habib
    B Pessoa
    J Coelho
    T Patel
    R Tadayoni
    P Massin
    J Atorf
    A J Augustin
    Eye, 2017, 31 : 684 - 690
12345